BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
See today's BioWorld Asia
Home
» Other news to note for Aug. 4, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for Aug. 4, 2020
Aug. 4, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Acerus, Affinity, Agenus, Altum, Appili, Avacta, Bergenbio, Betta, Betterlife, Bolt, Celonic, Daewoong, Daiichi Sankyo, Eli Lilly, FSD, G1, Gen1e, Gilead, Grifols, Hansoh, Heat, Humanigen, Hutchison China, Iacta, Immunitybio, Immunome, Immunoprecise Antibodies, Inovio, Intravacc, Johnson & Johnson, Kyorin, Nascent, Neurorx, Neutrolis, Nichi-Iko, Osmotica, Otonomy, Pharmabcine, Piramal Enterprise, Promedica, Qilu, Redhill, Relief, Restorbio, Santen, Schrödinger, Sesen, Simcere, Soligenix, Stemedica Cell, Takeda, Terns, Teva, Theragen, Tscan, Viva, Wuxi Shuangliang.
BioWorld Asia
Briefs
Other news to note